Dry eye market in UK to surpass USD 221 million by 2028, attaining a CAGR of 4.2%
UK dry eye market by drug form (eye ointment, gel, liquid drops, others), by product (anti-inflammatory drugs, artificial lubricant eye drops, autologous serum eye drops), by distribution channel (hospitals, online pharmacies, pharmacies & drug stores, others), outlook & forecast, 2022-2028
The dry eye in UK market is expected to increase by USD 48.4 million, at a compound annual growth rate (CAGR) of 4.2% from 2022 to 2028, according to the latest edition of the Dry Eye Market in UK Report.
Read Full Report: https://gen-cons.com/store/dry-eye-market-in-uk\
The report covers market size and growth, segmentation, competitive landscape, trends and strategies for dry eye market in UK. It traces the market’s historic and forecast market growth. The report identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches. This study also provides an analysis of the impact of the COVID-19 crisis on the dry eye industry.
This industry report offers market estimates and forecasts of the UK market, followed by a detailed analysis of the drug form, product, and distribution channel. The UK market for dry eye can be segmented by drug form: eye ointment, gel, liquid drops, others. Dry eye market is further segmented by product: anti-inflammatory drugs, artificial lubricant eye drops, autologous serum eye drops. Based on distribution channel, the dry eye market is segmented into: hospitals, online pharmacies, pharmacies & drug stores, others.
By drug form: eye ointment, gel, liquid drops, others
By product: anti-inflammatory drugs, artificial lubricant eye drops, autologous serum eye drops
By distribution channel: hospitals, online pharmacies, pharmacies & drug stores, others
The market research report covers the analysis of key stake holders of the dry eye market in UK. Some of the leading players profiled in the report include Allergan plc (AbbVie Inc.), Bausch & Lomb Incorporated, I-MED Pharma, Inc., Johnson & Johnson, LGL Ltd., Novartis AG, Otsuka Pharmaceutical Co., Ltd. (OPC), Santen Pharmaceutical Co., Ltd., Teva Pharmaceutical Industries Ltd., Vision Direct Group Limited, among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
- To analyze and forecast the market size of the dry eye market in UK.
- To classify and forecast the dry eye market in UK based on drug form, product, distribution channel.
- To identify drivers and challenges for the dry eye market in UK.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the dry eye market in UK.
- To identify and analyze the profile of leading players operating in the dry eye market in UK.
Why Choose This Report
- Gain a reliable outlook of the dry eye market in UK forecasts from 2022 to 2028 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.